Chat with us, powered by LiveChat

Our news

Explore the latest news from Lhasa

Sign up to our newsletter

Lhasa Limited release Acrostic: A revolutionary read-across tool for assessing nitrosamine carcinogenicity

Lhasa Limited is pleased to announce the release of Acrostic, a cutting-edge read-across tool designed to enhance decision-making in establishing acceptable intake (AI) limits for novel and untested nitrosamines.

Refining chemical safety assessments through data sharing

Lhasa Limited is delighted to announce the release of new data to the Vitic Excipients database. Excipients, a pre-competitive data sharing initiative, facilitates the anonymous sharing of excipient and vehicle toxicity data, helping members streamline their risk assessments.

New data released to advance understanding of compound-specific acceptable exposure limits

Lhasa Limited is thrilled to announce the release of new data to Vitic Acceptable Intake (AI) and Permitted Daily Exposure (PDE) database users.

Lhasa Limited launches Consult Lhasa to provide expert scientific risk assessments worldwide

Lhasa Limited is proud to announce the launch of Consult Lhasa, a wholly owned Lhasa Limited subsidiary, dedicated to providing expert scientific risk assessments to the pharmaceutical industry.

Lhasa Limited unveils Mirabilis 4.2: A leap forward in customisation and control

Lhasa Limited is delighted to announce the release of Mirabilis 4.2, providing members with advanced customisation options, and a more streamlined user experience.

Empowering industry progression through collaborative data sharing

Lhasa Limited is delighted to announce the release of new data to its Vitic Aromatic Amines database users. The Aromatic Amines data sharing initiative is a collaboration of pharmaceutical organisations sharing data from Ames mutagenicity assays for primary aromatic amines.

Lhasa Limited release cutting-edge toxicity data to enhance chemical risk assessments

Lhasa Limited is delighted to announce the release of Vitic 2023.1.1, featuring updated genotoxicity, carcinogenicity, and sensitisation endpoints, designed to enhance chemical risk assessments.

Lhasa Limited release functionality to predict the carcinogenic potency of nitrosamines

In concordance with the latest regulatory guidance on establishing acceptable intake (AI) limits for N-Nitrosamines, Lhasa Limited is pleased to announce the addition of nitrosamine carcinogenic potency categorisation approach (CPCA) assessment functionality to the latest version of Derek Nexus!

Rapid expansion of the Nitrites database continues with latest data release

Lhasa Limited is delighted to announce the second release of new data to its Vitic Nitrites database users. The Nitrites data sharing initiative is a key part of our global response to the nitrosamine crisis.

Lhasa Limited and the EMA: A joint commitment to shared knowledge

Lhasa Limited announces their ongoing collaboration with the European Medicines Agency (EMA), welcoming them as members and users of all Lhasa software.